Working... Menu
Trial record 47 of 190 for:    Oral Cancer | ( Map: Mexico )

A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02711553
Recruitment Status : Active, not recruiting
First Posted : March 17, 2016
Last Update Posted : March 5, 2019
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : February 16, 2018
  Estimated Study Completion Date : December 15, 2019
  Certification/Extension First Submitted : February 8, 2019